News

PepGen Inc. Investor Alert: Join the Class Action Lawsuit

PepGen Inc. Investor Alert: Join the Class Action Lawsuit

Investors Urged to Join PepGen Inc. Lawsuit

The Schall Law Firm, a notable national shareholder rights litigation firm, has issued a reminder to investors regarding a class action lawsuit against PepGen Inc. ("PepGen" or "the Company") PEPG. The firm indicates violations of the Securities Exchange Act of 1934 and related regulatory rules have occurred.

Class Action Details and Eligibility

Shareholders who purchased PepGen securities between March 7, 2024, and March 3, 2025, are invited to reach out to the Schall Law Firm to discuss their eligibility for the class action lawsuit. This is an important opportunity for those who may have experienced losses as a result.

How to Participate

Participating in the lawsuit involves contacting the firm before the upcoming deadline on August 8, 2025. It's highly encouraged for those affected to take action and ensure they are represented within the potential class.

Understanding the Claims Against PepGen

The lawsuit claims that PepGen made false and misleading statements regarding its drug candidate PGN-EDO51. It alleges that the product was not as safe or effective as the Company had suggested. Moreover, the CONNECT2 study, crucial for potential FDA approval, was purportedly flawed and posed risks to trial participants.

Fact Insights

According to the complaint, these misstatements led to significant investor losses when the reality of the situation was revealed. The damage incurred by investors underscores the critical nature of transparency in corporate statements.

Contacting the Schall Law Firm for More Information

For any shareholders who believe they qualify, they should consider reaching out to Brian Schall at the Schall Law Firm. The firm is located at 2049 Century Park East, Suite 2460, with contact availability at 310-301-3335. Furthermore, inquiries can be directed through the firm's website.

The Importance of Representation in Securities Actions

It should be noted that the class defined by this action has not yet been certified. Until that certification happens, potential class members are not officially represented. Those who choose inaction may remain absent members of the class.

Conclusion: Safeguarding Investor Rights

The Schall Law Firm has a strong emphasis on protecting shareholder rights and represents investors globally. Their expertise in securities class action lawsuits is vital for those affected by misleading corporate communications.

Next Steps for Affected Investors

Investors are advised to act swiftly by reaching out to the Schall Law Firm, thus ensuring their participation in the ongoing legal actions against PepGen Inc.

Frequently Asked Questions

What should I do if I purchased PepGen stock during the class period?

If you bought PepGen stock between March 7, 2024, and March 3, 2025, it’s advisable to contact the Schall Law Firm to discuss potential participation in the class action lawsuit.

How can I contact the Schall Law Firm?

You can reach the firm by calling 310-301-3335 or visiting their website at www.schallfirm.com.

What are the risks involved in this lawsuit?

Like any legal action, participating in a lawsuit involves risks such as the outcome not being favorable. However, it provides a chance for potential recovery of losses.

Is there a deadline to join the class action?

Yes, the deadline to join the class action lawsuit is August 8, 2025. It is critical to act before this date.

What will happen if the class loses?

If the class action does not succeed, participants may not recover any losses. However, the potential for recovery often makes pursuing legal action worthwhile.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 58

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 161

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 58

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 85

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 162

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 126

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 144

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 100

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 104

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 114

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Future of Palantir: A Promising Investment Opportunity

Updated Category News Views 200

The Rise of Palantir Technologies Palantir Technologies (NYSE: PLTR) has emerged as a notable force in the stock market, especially in the field of artificial intelligence (AI). Known for its complex data analytics platforms, Palantir was founded after the September 11 attacks to offer essential software solutions to federal intelligence agencies, assisting them in...

Continue Reading
Castellum, Inc. Achieves Record Revenue and Debt Reduction

Updated Category News Views 176

Castellum, Inc. Reports Impressive Q2 Financial Results Castellum, Inc. (NYSE-American: CTM), a prominent player in cybersecurity, electronic warfare, and software services directed towards the federal government, recently unveiled its financial results for the second quarter of 2025. The results showcase a record revenue performance, enhanced operational efficiencies,...

Continue Reading
Revolutionary Ultra H2 Wheelset by Superteam Wheels Debuts

Updated Category News Views 441

Introducing the Ultra H2 Wheelset Superteam Wheels, a notable name in the cycling industry, has taken a major step forward with the launch of their Ultra H2 Special Edition Wheelset. This new product is set to redefine the standards of performance wheels, appealing to cycling enthusiasts who seek the perfect blend of speed, reliability, and design. Advanced Technology at...

Continue Reading
Family Care Center's IOP Secures Three-Year CARF Accreditation

Updated Category News Views 200

Family Care Center Achieves Notable CARF Accreditation Family Care Center, a prominent national provider in behavioral health care, has recently announced a significant milestone: its intensive outpatient program (IOP) has earned a coveted three-year accreditation from the Commission on Accreditation of Rehabilitation Facilities (CARF). This accomplishment not only...

Continue Reading
Entergy Boosts Quarterly Dividend to Support Shareholders

Updated Category News Views 169

Entergy Announces Dividend Increase for Shareholders Entergy's board of directors has recently made a significant decision to enhance shareholder value. They declared a quarterly dividend payment of $0.64 per share, marking a notable increase of $0.04 per share. This increment reflects the company's ongoing commitment to rewarding its investors. Dividend Payment Schedule...

Continue Reading